Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

When it came to the study’s secondary endpoints of survival, Telix pointed to a median overall survival (OS) rate of 12.4 ...

Results of study directed by Rodrigo Toledo, Head of the Vall d'Hebron Institute of Oncology's (VHIO) Biomarkers and Clonal ...

New data shows South County Fire’s cardiac arrest survival rate 1 is 71%, nearly double the national average. “Firefighters are very deliberately focused on providing the absolute best CPR for your ...

The gut microbiome has emerged as a potential factor in cancer pathogenesis, but its role in non-functioning pituitary neuroendocrine tumors (NF-PitNETs) remains unclear. This study aimed to elucidate ...

Advanced lung cancer, which has spread (metastasized) from the primary tumor to distant organs, is associated with lower survival rates. That's because lung cancer becomes more difficult to treat as ...

The approval was based on progression-free survival (PFS) and overall response rates (ORRs ... of Dana-Farber Cancer Institute, Boston, stated in a press release from Exelixis.

For melanoma, the more serious type of skin cancer, survival rates have improved significantly to 92pc, meaning nine out of 10 patients survive at least five years. Join the Irish Independent ...

It also pointed to 'cyclical, temporary, factors' such as higher interest rate expectations, increases in gas prices and 'elevated uncertainty'. The OBR now expects growth to average 1.75 per ...

With the latest overall survival win in hand, J&J believes it holds the key to ending Tagrisso’s long reign in first-line EGFR lung cancer ... the survival rates were 56% and 44%, respectively.